Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JBDr. Justin Bailey

    Dr. Justin Bailey

    Infectious Disease · HIV & AIDS Medicine
    Johns Hopkins Hospital
    justinbailey

    Research

    Structural repertoire of HCV broadly neutralizing antibodies targeting the E2 front layer supersite

    2026

    Via Structure

    Research

    Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent

    2026

    Via The Journal of General Virology

    Research

    HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohort

    2026

    Via The Journal of Clinical Investigation

    Research

    Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity

    2025

    Via Journal of Virology

    Research

    Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection

    2024

    Via Immunity

    Research

    Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance

    2024

    Via Immunity

    Research

    Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone

    2024

    Via Journal of Hepatology

    Research

    Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor

    2023

    Via Cell Reports

    Research

    Convergent antibody responses are associated with broad neutralization of hepatitis C virus

    2023

    Via Frontiers in Immunology

    Research

    Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV

    2023

    Via Journal of Acquired Immune Deficiency Syndromes

    Research

    Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication

    2022

    Via AIDS

    Research

    Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C

    2022

    Via Nature Communications

    Research

    Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals

    2022

    Via Nature Communications

    Research

    Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency

    2022

    Via The Journal of Clinical Investigation

    Research

    Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening

    2022

    Via Cell Reports